Clinical trial
Fast Titration Of Quetiapine Versus Currently Approved Titration
NCT00254813 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00254813 |
|---|---|
| Title | Fast Titration Of Quetiapine Versus Currently Approved Titration |
| Official title | Fast Titration Of Quetiapine Versus Currently Approved Titration: A Randomised, Multicentre, Parallel Group Open Trial In Schizophrenia And Schizoaffective Disorder |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Quetiapine |
| Enrollment | 150 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Nov 17, 2005 |
| Last update posted | Jan 26, 2011 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: